Abstract:The novel single nucleotide polymorphism (SNP), rs2046210, was identified in a breast cancer genome-wide association study of Chinese women. The SNP is located on 6q25.1 in proximity to the C6orf97 and estrogen receptor 1 (ESR1) genes. To replicate this susceptibility, a number of case-control studies have been conducted in various populations. However, some results were inconclusive due to the restriction of sample size or ethnic diversity. To derive a more precise estimation of the relationship between rs2046210 and genetic risk of breast cancer, we performed the first comprehensive meta-analysis which included 121,494 cases and 119,295 controls from 14 published studies. Overall, significant increased risk between the A allele of rs2046210 and breast cancer was found in the total population (allelic model: OR = 1.16, 95 %CI = 1.11-1.21, P (heterogeneity) < 0.0001; dominant model: OR = 1.22, 95 %CI = 1.14-1.29, P (heterogeneity) < 0.0001; recessive model: OR = 1.21, 95 %CI = 1.13-1.29, P (heterogeneity) < 0.0001). When stratified by ethnicity, significant elevated risk was found among Europeans and Asians. However, no significant association was detected in African descent population. In the subgroup analyses according to estrogen receptor (ER) positive/negative status, our results suggested that this polymorphism tended to increase breast cancer risk in ER negative tumors by a greater magnitude compared to ER positive tumors. In addition, our subgroup analysis also indicated that this SNP was significantly associated with the risk of breast cancer for BRCA1 mutation carriers and exhibited weaker association with the risk for BRCA2 mutation carriers. Substantial heterogeneity was present in the overall analysis, but largely disappeared after stratification by ethnicity. Despite some limitations, this meta-analysis demonstrates that the rs2046210 polymorphism may be a risk factor associated with increased breast cancer risk. However, the association varies in different ethnicities.

Lack of Association Between the COMT Rs4680 Polymorphism and Ovarian Cancer Risk: Evidence from a Meta-analysis of 3,940 Individuals

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case-control studies.

Contribution of Catechol-O-Methyltransferase Val158met Polymorphism to Endometrial Cancer Risk in Postmenopausal Women: A Meta-Analysis

Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women

Catechol-O-methyltransferase 158G/A polymorphism and endometriosis/adenomyosis susceptibility: A meta-analysis in the Chinese population

No Association Of Catechol-O-Methyltransferase Polymorphisms With Schizophrenia In The Han Chinese Population

Association analysis ofCOMT polymorphisms and schizophrenia in a Chinese Han population: A case-control study

[Prevalence of Val158Met Polymorphism in COMT Gene on Non-Brca1/2 Hereditary Breast Cancer].

Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome

Lack of Association of Two Common Polymorphisms Rs2910164 and Rs11614913 with Susceptibility to Hepatocellular Carcinoma: a Meta-Analysis.

Association of rs 6505162 polymorphism in pre-miR-423 with cancer risk : a meta-analysis based on 5 , 891 cases and 7 , 622 controls

A Multigenic Study on Breast Cancer Risk Associated with Genetic Polymorphisms of ER Alpha , COMT and CYP19 Gene in BRCA1/BRCA2 Negative Shanghai Women with Early Onset Breast Cancer or Affected Relatives

Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects

Association Between the TERT Genetic Polymorphism Rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls.

Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis

The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis

The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer

Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.

Association Between a Novel Polymorphism (rs2046210) of the 6q25.1 Locus and Breast Cancer Risk